ELC22-FCE7: Findings of the Best Evidence Consensus on Biologics (a benefit of the BEC sponsorships - BioHorizons, Geistlich Biomaterials, Lynch Biologics, Straumann)
Seminar Information
Seminar Date:
October 27, 2022
Seminar Objectives
  • Identify the clinical indications of different biologics currently available for use in clinical practice.
  • Know the evidence supporting the use of biologics for the treatment of mucogingival deformities and periodontal infrabony defects, and for alveolar ridge preservation and implant site development.
  • Recognize the benefits, limitations, and potential risks associated with the use of biologics in periodontal practice
Course Editor: ELC22-FCE7: Findings of the Best Evidence Consensus on Biologics (a benefit of the BEC sponsorships – BioHorizons, Geistlich Biomaterials, Lynch Biologics, Straumann)
Individual topic purchase: Selected
ADA CERP
CE: 1.50
Products
On-Demand
AAP Price:$69.00